Plant compound slows cervical cancer growth in preclinical model

Updated on: August 12,2025 0

Plant compound slows cervical cancer growth in preclinical model

Updated on:August 12,2025 0

Over-the-counter pill boosts access to contraception, study finds

Updated on: September 03,2025 0

Over-the-counter pill boosts access to contraception, study finds

Updated on:September 03,2025 0

Controlled physical barrier created to boost cancer immunotherapy

Updated on: August 13,2025 0

Controlled physical barrier created to boost cancer immunotherapy

Updated on:August 13,2025 0

Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50–60% of users

Updated on: August 08,2025 0

Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50–60% of users

Updated on:August 08,2025 0

Mutational signatures and tumor activity identified in Chinese patients

Updated on: September 05,2025 0

Mutational signatures and tumor activity identified in Chinese patients

Updated on:September 05,2025 0

New insights into ovarian cancer: Why whole-genome doubling may hold the key to future HGSOC treatment strategies

Updated on: August 13,2025 0

New insights into ovarian cancer: Why whole-genome doubling may hold the key to future HGSOC treatment strategies

Updated on:August 13,2025 0

FDA plans to use AI to speed up drug and food safety reviews

Updated on: July 11,2025 0

FDA plans to use AI to speed up drug and food safety reviews

Updated on:July 11,2025 0

Do heart attack patients still need beta blockers? A cardiologist explains

Updated on: September 29,2025 0

Do heart attack patients still need beta blockers? A cardiologist explains

Updated on:September 29,2025 0

Doctors use Prozac to treat rare form of epilepsy: Case study

Updated on: September 03,2025 0

Doctors use Prozac to treat rare form of epilepsy: Case study

Updated on:September 03,2025 0

Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer

Updated on: September 29,2025 0

Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer

Updated on:September 29,2025 0